Literature DB >> 10722470

Paradoxical reaction syndrome complicating aural infection due to Mycobacterium tuberculosis during therapy.

A Safdar1, A E Brown, D H Kraus, M Malkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10722470     DOI： 10.1086/313731

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Fatal tuberculous meningitis caused by immune restoration disease.

Authors:  Hagen B Huttner; Rainer Kollmar; Andreas Hug; Fabian Meisel; Bodo Kress; Stefan Schwab
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

Review 2.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Severe paradoxical reaction requiring tracheostomy in a human immunodeficiency virus (HIV)-negative patient with cervical lymph node tuberculosis.

Authors:  In-Suh Park; Dongwook Son; Chanwoo Lee; Jae Eun Park; Jin-Soo Lee; Moon-Hyun Cheong; Young Mo Kim
Journal:  Yonsei Med J       Date:  2008-10-31       Impact factor: 2.759

Review 4.  Immune reconstitution inflammatory syndrome associated with biologic therapy.

Authors:  Malika Gupta; Kashif Jafri; Rebecca Sharim; Susanna Silverman; Sayantani B Sindher; Anupama Shahane; Mildred Kwan
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.919

5.  Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?

Authors:  Marie-Thérèse Ruf; Annick Chauty; Ambroise Adeye; Marie-Françoise Ardant; Hugues Koussemou; Roch Christian Johnson; Gerd Pluschke
Journal:  PLoS Negl Trop Dis       Date:  2011-08-02

6.  Paradoxical reaction in tubercular meningitis resulting in involvement of optic radiation.

Authors:  Parveen K Monga; Upreet Dhaliwal
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.